NSE · EPIGRAL
Epigral Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹746 Cr with net profit ₹64 Cr — a 8.64% net margin, versus 14.06% the period before.
Shareholding
As of 2026-09-30
- Promoter68.83%
- Public25.29%
- FII0.99%
- DII4.9%
76,384 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.1× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Chemicals · ranked #38 of 161 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Solar Industries India Ltd. | ₹1,68,384 Cr | 74.39 | 21.93 | 29.5% | 17.7% |
| Pidilite Industries Ltd. | ₹1,60,827 Cr | 59.92 | 14.32 | 23.94% | 16.63% |
| SRF Ltd. | ₹72,932 Cr | 30.88 | 4.81 | 14.92% | 12.76% |
| Linde India Limited | ₹58,496 Cr | 118.36 | 13.32 | 11.26% | 18.08% |
| Gujarat Fluorochemicals Ltd. | ₹51,251 Cr | 75.18 | 6.1 | 7.97% | 11.43% |
| Navin Fluorine International Ltd. | ₹46,234 Cr | 50.46 | 10.36 | 20.41% | 22.4% |
| Godrej Industries Ltd. | ₹32,198 Cr | 26.32 | 2.88 | 11.1% | 5.06% |
| Himadri Speciality Chem Limited | ₹28,667 Cr | 33.54 | 5.59 | 16.65% | 15.28% |
| Deepak Nitrite Ltd. | ₹20,917 Cr | 19.53 | 3.23 | 16.4% | 10.9% |
| Aether Industries Limited | ₹20,731 Cr | 82.24 | 7.99 | 9.61% | 19.21% |
| Epigral Limited(this company) | ₹3,940 Cr | 13.83 | 1.67 | 12.05% | 10.23% |
AI analysis
AI-generated · google/gemini-2.5-flashEpigral Limited, trading as EPIGRAL, has a market capitalization of Rs 4673 Cr. The company reported revenue of Rs 2542.16 Cr and a profit margin of 13.14%. Its earnings per share (EPS) stood at Rs 76.38, with a return on equity (ROE) of 14.94% and return on capital employed (ROCE) of 14.69%. The debt-to-equity ratio was 0.28.
Positives
- +The debt-to-equity ratio is low at 0.28.
- +The promoter holding is substantial at 68.8285%.
- +There are no promoter shares pledged (0%).
- +The company is not under surveillance.
Negatives
- −Revenue growth for the annual period ending March 2026 was negative at -0.9%.
- −Promoter holding has decreased from 71.1805% in March 2022 to 68.8285% in June 2026.
- −FII holdings have decreased from 1.1457% in December 2022 to 1.0341% in June 2026.
- −The dividend yield is unspecified at 46%, making assessment difficult.
Financial Performance
Epigral Limited reported annual revenue of Rs 2542.16 Cr as of March 2026. The revenue growth stood at -0.9%. The net profit for the same period was Rs 331.97 Cr. The company's EPS was Rs 76.38 for the period ending March 2026.
Profitability & Returns
The company recorded a profit margin of 13.14%. Return on equity (ROE) for Epigral Limited was 14.94%, and return on capital employed (ROCE) was 14.69%. The earnings per share (EPS) were Rs 76.38.
Balance Sheet
Epigral Limited maintained a debt-to-equity ratio of 0.28, indicating a low level of debt relative to equity. The book value per share was Rs 514.92.
Ownership & Pledges
As of June 30, 2026, promoter holding in Epigral Limited was 68.8285%. Domestic Institutional Investors (DII) held 5.5596%, while Foreign Institutional Investors (FII) held 1.0341%. Public shareholding was 24.5778%. There were no promoter pledges reported (0%).
Regulatory & Surveillance
The company is not currently under any surveillance measure.
Data as of — price: 2026-11-07 · financials: Sep 26 · shareholding: Sep 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.